Zhangzhou Pientzehuang Pharmaceutical Co Ltd
SSE:600436

Watchlist Manager
Zhangzhou Pientzehuang Pharmaceutical Co Ltd Logo
Zhangzhou Pientzehuang Pharmaceutical Co Ltd
SSE:600436
Watchlist
Price: 247.96 CNY -1.22% Market Closed
Market Cap: 149.6B CNY
Have any thoughts about
Zhangzhou Pientzehuang Pharmaceutical Co Ltd?
Write Note

Zhangzhou Pientzehuang Pharmaceutical Co Ltd
Gross Profit

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

Zhangzhou Pientzehuang Pharmaceutical Co Ltd
Gross Profit Peer Comparison

Comparables:
600196
H
3692
600276
000538
S
688506

Competitive Gross Profit Analysis
Latest Figures & CAGR of Competitors

Company Gross Profit CAGR 3Y CAGR 5Y CAGR 10Y
Zhangzhou Pientzehuang Pharmaceutical Co Ltd
SSE:600436
Gross Profit
ÂĄ4.8B
CAGR 3-Years
13%
CAGR 5-Years
17%
CAGR 10-Years
21%
Shanghai Fosun Pharmaceutical Group Co Ltd
SSE:600196
Gross Profit
ÂĄ18.8B
CAGR 3-Years
2%
CAGR 5-Years
3%
CAGR 10-Years
15%
H
Hansoh Pharmaceutical Group Company Ltd
HKEX:3692
Gross Profit
ÂĄ9.1B
CAGR 3-Years
5%
CAGR 5-Years
5%
CAGR 10-Years
N/A
Jiangsu Hengrui Pharmaceuticals Co Ltd
SSE:600276
Gross Profit
ÂĄ21.4B
CAGR 3-Years
-6%
CAGR 5-Years
5%
CAGR 10-Years
15%
Yunnan Baiyao Group Co Ltd
SZSE:000538
Gross Profit
ÂĄ10.5B
CAGR 3-Years
2%
CAGR 5-Years
5%
CAGR 10-Years
8%
S
Sichuan Biokin Pharmaceutical Co Ltd
SSE:688506
Gross Profit
ÂĄ319.6m
CAGR 3-Years
-27%
CAGR 5-Years
N/A
CAGR 10-Years
N/A

See Also

What is Zhangzhou Pientzehuang Pharmaceutical Co Ltd's Gross Profit?
Gross Profit
4.8B CNY

Based on the financial report for Jun 30, 2024, Zhangzhou Pientzehuang Pharmaceutical Co Ltd's Gross Profit amounts to 4.8B CNY.

What is Zhangzhou Pientzehuang Pharmaceutical Co Ltd's Gross Profit growth rate?
Gross Profit CAGR 10Y
21%

Over the last year, the Gross Profit growth was 15%. The average annual Gross Profit growth rates for Zhangzhou Pientzehuang Pharmaceutical Co Ltd have been 13% over the past three years , 17% over the past five years , and 21% over the past ten years .

Back to Top